INTRODUCTION
The genetic susceptibility to chronic pancreatitis (CP) is best illustrated by the discovery of cationic trypsinogen mutations (PRSS1 HGNC:9475) in families with autosomal-dominant inherited pancreatitis. 1 There is also strong evidence that genetic variants
Significance of this study
What is already known on this subject?
▸ Genetic associations for non-alcoholic chronic pancreatitis (NACP) in PRSS1, PRSS2, CFTR, SPINK1, CTRC and CPA1, as well as a gene-dosage effect of PRSS1-PRSS2 locus have been identified. ▸ Alcohol misuse is the predominant cause of chronic pancreatitis (CP); however, only 3%-5% of alcohol misusers develop the disease. This implicates genetic susceptibility factors, which have not been elucidated so far. ▸ A recent genome-wide association study (GWAS) reported PRSS1-PRSS2 and CLDN2-MORC4 locus variants that affect risk for CP, and the data have not been replicated up to now.
What are the new findings?
▸ This study in a large European cohort replicates and refines the impact of PRSS1-PRSS2 and CLDN2-MORC4 locus variants as susceptibility factors predominantly in ACP. ▸ Variants at both loci are susceptibility factors for ACP and not alcohol misuse per se according to our comparison with alcoholdependent and patients with alcoholic liver cirrhosis. ▸ Risk increase for the X chromosomal CLDN2-MORC4 locus is comparable in men and women. As such this factor does not explain any sex differences in disease susceptibility.
How might it impact on clinical practice in the foreseeable future?
▸ The replication and refinement of the recently identified susceptibility variants justifies further studies on their functional properties. ▸ By the identification of new pathways, new strategies for influencing the clinical picture of NACP and ACP might be developed in the long term.
contribute to cases of CP without a clear inheritance pattern. Indeed, idiopathic CP (ICP) is associated with genetic alterations in CFTR (HGNC:1884), SPINK1 (HGNC:11244), PRSS2 (HGNC:9483), CTRC (HGNC:2523) and CPA1 (HGNC:2296). [2] [3] [4] [5] [6] [7] The association of genetic variants and disease susceptibility is less clear for alcohol-related CP (ACP). There is a low enrichment of SPINK1 (p.N34S) and CTRC (p.R254W) alleles in ACP populations, and no other consistent genetic risk contributors have been described. 5 8 Similar to ICP, the PRSS2 p.G191R variant protects against ACP development.
2 All these associations have been discovered through candidate-driven genetic association studies.
A recent paper described a different approach and reported novel risk and protecting loci for CP identified through a genome-wide association study (GWAS). A number of variants in the PRSS1-PRSS2 but also the CLDN2-MORC4 locus (Claudin 2; HGNC:2041; RIPPLY1, ripply transcriptional repressor 1, HGNC:25117; MORC4, MORC family CW-type zinc finger 4, HGNC:23485) were captured as risk factors for CP. 9 This study investigated patients with different types of CP as well as recurrent acute pancreatitis (RAP) and stratified individuals into alcohol-related and alcohol-unrelated pancreatitis groups. In a first screening cohort, three single nucleotide polymorphisms (SNPs) rs10273639 (in the PRSS1-PRSS2 locus on chromosome 7, in perfect linkage disequilibrium with rs2011216 in intron 1 and rs6667 in exon 5 of PRSS1), rs7057398 and rs12688220 (both in a new locus, CLDN2-MORC4 on the X chromosome) reached genome-wide significance. After scrutiny, the PRSS1-PRSS2 rs10273639 T allele appeared to protect against CP, whereas RIPPLY1 rs7057398 C allele and MORC4 rs12688220 T allele increased disease susceptibility. 9 There is some biological plausibility for the association with the PRSS1-PRSS2 locus as it may disturb the balance of pancreatic proteases and antiproteases in favour of the former. 10 11 Claudin 2 represents a tight junction protein involved in low-resistance cation-selective ion and water transport between endothelial cells. 12 13 One might speculate that CLDN2-MORC4 locus variants lead to miss-localisation of pancreatic CLDN2 that hampers its biological function. However, this speculation warrants further experimental support.
Prior to the design of experimental studies that focus on the biological role of these variants, it is crucial that GWAS results are replicated. This is needed to prove that results are valid and reliable to determine generalisability and to better judge the effect size of the discovered association. 14 We investigated the association of PRSS1-PRSS2 and CLDN2-MORC4 locus variants in a large European cohort of ACP and non-alcoholic CP (NACP) to confirm the former finding. In order to assess the effect of alcohol consumption, we further refined our analyses by including cohorts of patients with alcohol-associated cirrhosis (ALC) as well as with alcohol dependence (AD) without hepatic or pancreatic disease.
MATERIALS AND METHODS Study subjects
The respective medical ethical review committees of all participating centres approved the study protocol and all patients gave written informed consent. The diagnosis of CP was based on two or more of the following findings: (a) presence of a typical history of recurrent pancreatitis or (b) recurrent abdominal pain typical for CP, (c) calcifications and/or (d) pancreatic ductal irregularities revealed by imaging of the pancreas. 15 ACP was diagnosed in patients who had consumed at least 80 g ethanol per day for at least 2 years in men or 60 g per day for women.
We labelled patients with NACP in the absence of exogenous factors such as alcohol.
ALC was diagnosed by a history of habitual ethanol intake (see ACP diagnosis above, duration at least 10 years), typical findings in liver biopsy or clinical and laboratory findings indicative for liver disease. Such laboratory and clinical findings included abnormal levels of aminotransferases, gamma glutamyl transpeptidase, coagulation tests, serum albumin concentration, platelet count, complications related to liver cirrhosis such as oesophageal varices, ascites, hepatic encephalopathy and typical liver morphology in imaging studies. Other aetiologies of liver cirrhosis were excluded by standard laboratory tests.
Patients with AD were recruited from psychiatric and addiction medicine departments in different cities across southern and central Germany. AD was diagnosed per DSM-IV criteria by consensus of two clinical psychiatrists. All patients were of selfreported German ancestry and did not suffer from CP or ALC. 16 The study included 1866 patients (male, n=1567) with ACP and 1196 patients (male, n=596) with NACP from different European countries. In addition, we enrolled 5107 controls (male, n=2287), 661 German patients with ALC (male, n=480) and 898 Germans with AD (male, n=797). Characteristics of the patients and controls are summarised in table 1. More details of the controls are summarised in online supplementary table S1.
Genotyping
Details of the methods used for genotyping are summarised in the online supplementary material. As quality controls, 3% of all samples were genotyped in duplicates blinded to the investigator. The concordance rate was >98%. Call rates for rs10273639, rs7057398 and rs12688220 in the European samples were 99.1% (9641/9730), 99% (9636/9730) and 98.8% (9609/9730), respectively.
Statistical analysis
Quality of SNP genotypes was assessed by study-wise call rate and exact test for Hardy-Weinberg equilibrium in controls (female controls only for the X chromosomal SNPs). We also calculated overall statistics and performed stratified tests of Hardy-Weinberg equilibrium according to Troendle and Yu. 17 According to these measures, genotype qualities were excellent throughout. Study-wise genetic effects were determined by logistic regression analysis assuming an additive model of inheritance. For X chromosomal SNPs, we analysed the subgroups of men and women separately. Following the approach of Loley et al, 18 we also determined combined effects by either assuming a model of complete X inactivation (XIA) or no X inactivation (nXIA) at all. The major purpose of our study is to compare allele frequencies of risk variants between different subgroups of patients (ACP, NACP) and controls (healthy, alcohol dependent, patients with cirrhosis). Corresponding contrasts of interest are listed in online supplementary table S2. Study-wise effects were pooled by standard meta-analysis techniques as implemented in the package 'meta' of the statistical software 'R 3.0.1' (ww.r-project.org). Heterogeneity between studies was assessed using Q-statistics. Due to occasionally observed study heterogeneity, we calculated random-effect models throughout. For the purpose of model diagnostics, we analysed and compared likelihoods of XIA, nXIA and sex interaction. In figures 1, 2A, B, 3 , 4A, B and 5, we present forest plots of our meta-analysis results as well as other features. Finally, we performed a stratified analysis regarding age of onset in the German population. Forest plots were generated using GraphPad Prism (V.6.0a) (San Diego). p Values <0.05 were considered statistically significant.
Online supplementary figures S1a, b and S2a, b display the results of X chromosomal analysis assuming models of complete or no X inactivation.
RESULTS

PRSS1-PRSS2 locus (rs10273639)
In meta-analysis, rs10273639 showed the strongest association with ACP (OR 0.63, 95% CI 0.55 to 0.72, p value 8.5×10 −11 ). In addition, the SNP is not associated with risk of cirrhosis or AD, neither for men nor for women. Figure 2A , B summarises the results of the meta-analysis of rs7057398 in patients with ACP. Results of XiA and nXiA are summarised in online supplementary figure S1a, b.
The genotype and allele frequencies of rs7057398 in patients with ACP are presented in online supplementary tables S5 and S6. The C allele was more frequent in male patients with ACP from all European countries investigated (43.8% vs controls 27.5%, p value 10×10 ) and the C allele was significantly overrepresented ( p value 0.0001) in female patients with ACP (35.2%) compared with controls (27.3%).
We detected a significant association for rs7057398 with NACP upon logistic regression in female patients (OR 1.30, 95% CI 1.14 to 1.49, p value 1.3×10 −4 ), but not in male patients (figure 3). Estimated genetic effect sizes are always smaller than for ACP. As shown in Supplementary tables S7 and S8, the C allele was slightly overrepresented in male patients with NACP (all patients: 32.6% vs 28.3%, p value 0.04; German patients: ) and female patients (OR 1.71, 95% CI 1.41 to 2.07, p value 3.3×10 −8 ) with ACP ( figure 4A, B) . The association was also statistically significant in individual male cohorts from Germany, France, Spain, the Netherlands, Italy and Romania ( p value 1.2×10 Online supplementary tables S9 and S10 summarise the genotype and allele distribution of rs12688220 in ACP. The T allele was overrepresented in all European male cohorts (men: all patients 43.9% vs all controls 25.1%, p value 4.6×10 −33 ), while in female ACP cohorts from Germany, Poland and the UK as well as in the overall female group the overrepresentation of the TT genotype was statistically significant (women: all patients 10.4% vs all controls 6.7%, p value 2.4×10 −7 ). In the meta-analysis, we detected no significant association in the overall male and female NACP group ( p value 0.2 and 0.1). Again, genetic effect sizes are clearly smaller than for ACP. In single-study analyses, significant differences were found in the German NACP female group (OR 1.41, 95% CI 1.18 to 1.68, p value 0.0002) and in the male NACP groups from Germany (OR 1.34, 95% CI 1.03 to 1.75, p value 0.03) and the Netherlands (OR 2.09, 95% CI 1.05 to 4.12, p value 0.03) (figure 5).
Again, no differences were observed between the three control groups. Genotype and allele distributions of this variant can be found in online supplementary tables S11 and S12.
Additional analyses
We pooled our cases and control groups in order to compare our results with the analysis published by Whitcomb et al. Results are summarised in online supplementary table S13 for all SNPs. Strong associations were observed for all variants, that is, the results of Whitcomb et al are clearly replicated.
To analyse whether effect sizes of X chromosomal variants are different between male and female patients, we performed sex-interaction analysis but interaction terms were not significant throughout (results not shown). We also compared the models of XIA and nXIA and observed a non-significant trend that XIA is more likely.
Finally, in order to better understand the lack of associations for NACP, we performed a stratified analysis of the German cohort regarding age of onset. Interestingly, we observed a trend towards higher genetic effect sizes in groups of later age of onset. This could explain, for example, the lack of associations in the French cohort in which the age range is 1-20 years (see online supplementary table S14).
DISCUSSION
This case-control study replicates and refines a robust association between a PRSS1-PRSS2 locus variant (rs10273639) and CP. This is particularly strong in ACP and not apparent in NACP. The effect is independent from alcohol consumption as the difference in allele frequency remained upon comparison with other alcohol-related disorders (ALC and AD). The risk reduction by rs10273639 was higher in our overall ACP cohort (OR 0.63, CI 0.55 to 0.72) compared with the overall GWAS data (OR 0.73, seOR 0.029), which might be explained by the mixture of different aetiologies of patients with CP and RAP in the recent publication. 9 When using a comparable analysis strategy, similar results were obtained (see online supplementary table S13; OR 0.71, CI 0.61 to 0.84). Thus, the T allele confers protection against the development of ACP, but not against NACP. The protective effect of the T allele was observed for all single studies except for the samples from Poland. Genetic effect sizes vary between OR=0.41 (Romania) to OR=1.0 (Poland). However, this can be explained by small sample sizes rather than ethnic differences.
What is the biological background of our findings? The PRSS1-PRSS2 locus SNP rs10273639 (c.−408T>C) is located 408 nucleotides upstream of the ATG start codon of PRSS1 and as such might influence PRSS1 expression. Indeed, the SNP seems to correlate with PRSS1 mRNA levels in 69 pancreas tissue samples pointing towards its role in the regulation of PRSS1 expression. 9 Trypsinogen expression was lowest in TT genotypes, which suggests that this genotype might protect against pancreatitis development. However, the normalised gene expression data from pancreatic tissue had high SEs and a p value of 0.01 after removal of two outliers and, therefore, probably warrant further evidence to support this assumption. 9 In addition, SNPs rs2011216 and rs6667 were found to be in linkage disequilibrium with rs10273639 and as such the biological effect might be related to those or even other SNPs.
We obtained similar results for the CLDN2-MORC4 locus SNPs. We discovered that an association of both the RIPPLY1 and the MORC4 SNP with ACP was present in men and in women. Genetic effect sizes in men were somewhat higher than in women (OR=2.66 compared with OR=1.71 for MORC4 and OR=2.27 compared with OR=1.56 for RIPPLY1), but no significant SNP-sex interactions were found. The associations with NACP were weaker throughout and not significant except for the RIPPLY1 variant in female patients.
In older epidemiological studies, it was shown that women developed ACP at an earlier age and after consumption of a lower total amount of alcohol than men. 19 20 It is a matter of debate whether genetic effects at chromosome X can explain this observation. However, in our study, the genetic effect sizes of men and women were not significantly different for the variants considered. Moreover, by comparing models with and without assuming X inactivation, we did not receive a clear preference towards one of these assumptions. In view of these results, the X chromosomal CLDN2-MORC4 locus variants do not even partly explain the higher ACP risk in men.
The role of CLDN2/RIPPLY1/MORC4 in pancreatitis is less clear. As a tight junction protein CLDN2 is involved in lowresistance cation-selective ion and water transport between endothelial cells. 12 13 The functional consequence of each investigated SNP is rather unclear so far. The recent paper proposed an atypical localisation of CLDN2 in acinar cells and an increase of CLDN2 expression in one investigated CP pancreas specimen (cDNA expression level) as well as in Western blot analyses from 19 pancreas specimens with different genotypes. Both for MORC4 and RIPPLY1 as well as for TBC1D8B, another gene within the CLDN2 locus, the recent paper proposed no relevance for CP development.
For the X chromosomal variants, the effect sizes were smaller in a recently published GWAS. 9 Again, this can be explained by the markedly observed stronger genetic effect sizes of ACP compared with NACP. The aetiology of AD involves environmental and genetic factors. Its heritability is estimated at ∼50%. 21 Since patients with ACP were compared with controls without defined alcohol consumption in our study as well as in the published GWAS, the described SNPs might represent markers for alcoholism and not for ACP. However, when data of patients with ACP were compared with patients with alcohol-associated liver cirrhosis and alcohol dependence in our study, the association of all investigated SNPs was replicated with similar effect sizes. Therefore, we conclude that the association of the three SNPs is specific for ACP and is unrelated to AD or alcohol-related liver disease.
In summary, our data refine the results of the recently published GWAS. The PRSS1-PRSS2 rs10273639 T allele protects against development of ACP but not NACP. The X chromosomal RIPPLY1 and MORC4 SNPs showed strong association with ACP. For NACP, the associations are weaker and only significant for the RIPPLY1 SNP in women. The variants are not associated with the risk of AD or liver cirrhosis. The observed differences in SNP effects between ACP and NACP could be due to interactions of variants with alcohol consumption, which would amplify the risk, or they could result from differences in the pathophysiology of the two forms of CP. These hypotheses warrant future functional investigations. 
